126 related articles for article (PubMed ID: 36117467)
1. Genomic landscape of multiple Bowen's disease using whole-exome sequencing.
Kim YS; Park GS; Bang CH; Chung YJ
J Dermatol; 2023 Mar; 50(3):397-400. PubMed ID: 36117467
[TBL] [Abstract][Full Text] [Related]
2. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
[TBL] [Abstract][Full Text] [Related]
3. Whole-exome sequencing of secondary tumors arising from nevus sebaceous revealed additional genomic alterations besides RAS mutations.
Kim YS; Park GS; Chung YJ; Lee JH
J Dermatol; 2023 Aug; 50(8):1072-1075. PubMed ID: 36938660
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin.
Saridaki Z; Liloglou T; Zafiropoulos A; Koumantaki E; Zoras O; Spandidos DA
Br J Dermatol; 2003 Apr; 148(4):638-48. PubMed ID: 12752119
[TBL] [Abstract][Full Text] [Related]
5. From Bowen disease to cutaneous squamous cell carcinoma: eight markers were verified from transcriptomic and proteomic analyses.
Biao T; Cai-Feng H; Xiao-Hong L; Xiao-Li C; Wen-Bei L; Jun W; Chao C; Tao Y
J Transl Med; 2022 Sep; 20(1):416. PubMed ID: 36085041
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin.
Campbell C; Quinn AG; Ro YS; Angus B; Rees JL
J Invest Dermatol; 1993 Jun; 100(6):746-8. PubMed ID: 8496613
[TBL] [Abstract][Full Text] [Related]
7. p53 mutation spectrum in Japanese Bowen's disease suggests a role for mutagens other than ultraviolet light.
Takata M; Rehman I; Rees JL
Int J Cancer; 1997 May; 71(3):370-2. PubMed ID: 9139870
[TBL] [Abstract][Full Text] [Related]
8. High frequency of DNA aneuploidy detected by DNA flow cytometry in Bowen's disease.
Kawara S; Takata M; Takehara K
J Dermatol Sci; 1999 Sep; 21(1):23-6. PubMed ID: 10468188
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 promoter -56 and -54bp CpG un-methylation predicts invasive progression in arsenic-induced Bowen's disease.
Liao WT; You HL; Chai CY; Lee CH; Lan CE; Chang SJ; Yu CL; Yu HS
J Dermatol Sci; 2018 Feb; 89(2):191-197. PubMed ID: 29103775
[TBL] [Abstract][Full Text] [Related]
10. Aneuploidy in Bowen's disease.
Newton JA; Camplejohn RS; McGibbon DH
Br J Dermatol; 1986 Jun; 114(6):691-4. PubMed ID: 3718863
[TBL] [Abstract][Full Text] [Related]
11. Increased chromosome aberration frequencies in the Bowen's patients compared to non-cancerous skin lesions individuals exposed to arsenic.
Ghosh P; Banerjee M; De Chaudhuri S; Das JK; Sarma N; Basu A; Giri AK
Mutat Res; 2007 Aug; 632(1-2):104-10. PubMed ID: 17600756
[TBL] [Abstract][Full Text] [Related]
12. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
[TBL] [Abstract][Full Text] [Related]
13. p53 gene mutations in Bowen's disease in Koreans: clustering in exon 5 and multiple mutations.
Lee HJ; Kim JS; Ha SJ; Roh KY; Seo EJ; Park WS; Lee JY; Park KS; Kim JW
Cancer Lett; 2000 Sep; 158(1):27-33. PubMed ID: 10940505
[TBL] [Abstract][Full Text] [Related]
14. Mutational Landscape of Normal Human Skin: Clues to Understanding Early-Stage Carcinogenesis in Keratinocyte Neoplasia.
Kim YS; Bang CH; Chung YJ
J Invest Dermatol; 2023 Jul; 143(7):1187-1196.e9. PubMed ID: 36716918
[TBL] [Abstract][Full Text] [Related]
15. Germ line TP53 mutation in a patient with multiple Bowen's disease.
Hatta N; Hatta Y
J Dermatol; 2019 Jun; 46(6):e198-e200. PubMed ID: 30592087
[No Abstract] [Full Text] [Related]
16. Arsenic-related Bowen's disease and paraquat-related skin cancerous lesions show no detectable ras and p53 gene alterations.
Hsieh LL; Chen HJ; Hsieh JT; Jee SH; Chen GS; Chen CJ
Cancer Lett; 1994 Oct; 86(1):59-65. PubMed ID: 7954356
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical staining of palisading basal cells in Bowen's disease and basal involvement in actinic keratosis: contrasting staining patterns suggest different cells of origin.
Saglam O; Salama M; Meier F; Chaffins M; Ma C; Ormsby A; Lee M
Am J Dermatopathol; 2008 Apr; 30(2):123-6. PubMed ID: 18360114
[TBL] [Abstract][Full Text] [Related]
18. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
[TBL] [Abstract][Full Text] [Related]
19. A clonal t(9;12)(q32;q21) in cultured fibroblasts from a case of Bowen's disease.
Scappaticci S; Lambiase S; Fraccaro M; Orecchia G
Cancer Genet Cytogenet; 1989 Dec; 43(2):249-50. PubMed ID: 2598169
[No Abstract] [Full Text] [Related]
20. Comparative histochemical study of Bowen's disease and actinic keratosis: preserved normal basal cells in Bowen's disease.
Ishida H; Kumakiri M; Ueda K; Lao LM; Yanagihara M; Asamoto K; Imamura Y; Noriki S; Fukuda M
Eur J Histochem; 2001; 45(2):177-90. PubMed ID: 11512639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
